Protonix IV (pantoprazole), the first INTRAVENOUS proton pump inhibitor

April 2001

Wyeth will soon market Protonix IV (pantoprazole), the first INTRAVENOUS proton pump inhibitor.

Until now, hospitalized patients who couldn't take an oral proton pump inhibitor had to get an intravenous H2-blocker.

Protonix IV is officially approved only for short-term treatment in GERD patients...but it will be widely used for other patients who can't take oral acid-suppressing drugs.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote